Beta blockers after TAVI in high-risk adults with valve narrowing
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether stopping beta blockers after TAVI is safe and effective compared with continuing them. It may help clarify the best medication plan after valve replacement for people at higher surgical risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older) with severe aortic valve narrowing that needs TAVI
- You must have symptoms from this valve problem and be considered high risk for open-heart surgery
- You are currently taking beta blockers as part of your usual treatment
- A heart specialist team must agree that TAVI is suitable for your heart anatomy
- You must be able and willing to do follow-up visits and sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial compares two blood thinners (ticagrelor and aspirin) to see which one works better at preventing blood clots after a less-invasive heart valve replacement (TAVI). It is for people with severe aortic stenosis who also have diabetes, heart disease, or artery disease.
This study compares regular monitoring (“clinical surveillance”) versus replacing the aortic valve using a minimally invasive procedure called TAVR for people with moderate aortic stenosis. It aims to see which approach better reduces symptoms or heart damage over time.
This trial studies a faster, emergency version of a valve replacement done through the blood vessels (TAVI) for people with severe aortic valve narrowing. It aims to check whether this approach is safe and works when people are in urgent, hard-to-stabilize situations.
This study compares two treatments for severe aortic stenosis in people with a bicuspid aortic valve: transcatheter aortic valve replacement (TAVR, a less invasive procedure) and surgical aortic valve replacement (SAVR, open-heart surgery). The goal is to see which approach works better for this specific condition.
This study tests whether continuing a beta-blocker (a heart medication) improves outcomes for people having a planned TAVR (a minimally invasive heart-valve replacement). It may help doctors decide whether to keep or stop this medicine after the procedure.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.